JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
Apple
AAPL
|
+$5.25B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.24B |
| 3 |
Microsoft
MSFT
|
+$2.17B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Broadcom
AVGO
|
+$1.54B |
Top Sells
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.19B |
| 3 |
Progressive
PGR
|
+$1.63B |
| 4 |
Adobe
ADBE
|
+$1.62B |
| 5 |
Salesforce
CRM
|
+$1.48B |
Sector Composition
| 1 | Technology | 25.26% |
| 2 | Healthcare | 9.71% |
| 3 | Consumer Discretionary | 9.24% |
| 4 | Financials | 9.04% |
| 5 | Industrials | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4376
LivePerson
LPSN
$86M
| $93.8K | ﹤0.01% |
161,600
+130,822
| +425% | +$75.9K |
|
|
LENZ
4377
LENZ Therapeutics
LENZ
$1.18B
| $93.7K | ﹤0.01% |
5,420
+3,738
| +222% | +$64.6K |
|
4378
Trevi Therapeutics
TRVI
$1B
| $93.4K | ﹤0.01% |
31,350
+5,887
| +23% | +$17.5K |
|
4379
Nuvectis Pharma
NVCT
$157M
| $93.4K | ﹤0.01% |
14,753
+9,588
| +186% | +$60.7K |
|
4380
Innovator US Equity Power Buffer ETF August
PAUG
$1.01B
| $93.4K | ﹤0.01% |
2,557
-58,633
| -96% | -$2.14M |
|
4381
Sleep Number
SNBR
$214M
| $93.3K | ﹤0.01% |
9,747
-32
| -0.3% | -$306 |
|
4382
Frontier Group Holdings
ULCC
$1.18B
| $92.9K | ﹤0.01% |
18,851
+2,970
| +19% | +$14.6K |
|
|
AOMR
4383
Angel Oak Mortgage REIT
AOMR
$232M
| $92.5K | ﹤0.01% |
7,059
-18,020
| -72% | -$236K |
|
|
ZH
4384
Zhihu
ZH
$464M
| $92.5K | ﹤0.01% |
+33,872
| New | +$92.5K |
|
4385
Orchestra BioMed
OBIO
$139M
| $92.3K | ﹤0.01% |
11,320
+5,124
| +83% | +$41.8K |
|
4386
EVI Industries
EVI
$348M
| $92.1K | ﹤0.01% |
4,867
-4,103
| -46% | -$77.6K |
|
4387
Fidelity D&D Bancorp
FDBC
$267M
| $92.1K | ﹤0.01% |
2,102
-5,432
| -72% | -$238K |
|
|
STEW
4388
SRH Total Return Fund
STEW
$1.77B
| $92K | ﹤0.01% |
6,320
-1,600
| -20% | -$23.3K |
|
|
AFCG
4389
AFC Gamma
AFCG
$105M
| $91.9K | ﹤0.01% |
11,009
-11,807
| -52% | -$98.6K |
|
4390
Pulse Biosciences
PLSE
$977M
| $91.5K | ﹤0.01% |
8,180
-1,053
| -11% | -$11.8K |
|
4391
Zevra Therapeutics
ZVRA
$435M
| $91.5K | ﹤0.01% |
18,665
+3,604
| +24% | +$17.7K |
|
4392
HighPeak Energy
HPK
$899M
| $91.4K | ﹤0.01% |
6,503
-6,595
| -50% | -$92.7K |
|
4393
Inovio Pharmaceuticals
INO
$126M
| $91.3K | ﹤0.01% |
11,296
+10,823
| +2,288% | +$87.5K |
|
4394
Inspired Entertainment
INSE
$253M
| $91.2K | ﹤0.01% |
9,969
+1,184
| +13% | +$10.8K |
|
4395
Clarus
CLAR
$147M
| $91K | ﹤0.01% |
13,525
+869
| +7% | +$5.85K |
|
4396
SkyWater Technology
SKYT
$509M
| $90.9K | ﹤0.01% |
11,881
+4,150
| +54% | +$31.7K |
|
4397
Akebia Therapeutics
AKBA
$782M
| $90.7K | ﹤0.01% |
88,884
+88,653
| +38,378% | +$90.4K |
|
|
HTZWW
4398
Hertz Global Holdings Warrants
HTZWW
$303M
| – | – |
0
| – | -$164K |
|
|
MRX
4399
Marex Group
MRX
$2.43B
| $90.3K | ﹤0.01% |
+4,516
| New | +$90.3K |
|
4400
Fidelity Enhanced Large Cap Core ETF
FELC
$5.12B
| $90.3K | ﹤0.01% |
2,950
-11,374
| -79% | -$348K |
|